Allogeneic Hematopoietic Cell Transplantation for Primary Immune Deficiency Diseases Current Status and Critical Needs

Allogeneic hematopoietic cell transplantation (HCT) has been employed for 40 years to ameliorate or cure primary immune deficiency (PID) diseases, including severe combined immune deficiency (SCID) and non-SCID PID. There is a critical need for evaluation of the North American experience of differen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Griffith, Linda M., Cowan, Morton J., Kohn, Donald B., Notarangelo, Luigi D., Puck, Jennifer M., Schultz, Kirk R., Buckley, Rebecca H., Eapen, Mary, Kamani, Naynesh R., O’Reilly, Richard J., Parkman, Robertson, Roifman, Chaim M., Sullivan, Kathleen E., Filipovich, Alexandra H., Fleisher, Thomas A., Shearer, William T.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3357108/
https://ncbi.nlm.nih.gov/pubmed/18992926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2008.09.045
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares